- Joined
- 1 October 2008
- Posts
- 3,733
- Reactions
- 388
Re: RMD - Resmed
Today's chart pattern is known as an ejaculation.
Could do worse than sell into it.
Today's chart pattern is known as an ejaculation.
Could do worse than sell into it.
tech/a
No Ordinary Duck
- Joined
- 14 October 2004
- Posts
- 20,299
- Reactions
- 6,001
Re: RMD - Resmed
Nottingham are you taking the pizz
Nottingham are you taking the pizz
- Joined
- 1 October 2008
- Posts
- 3,733
- Reactions
- 388
Re: RMD - Resmed
I think so Mr. Tech/a man.
Occasionally I attempt some humour.
It will likely go flat for a few days and even try a gap fill before reinvigorating for another leg up.
Doctors and nurses are still all the rage at the moment.
I think so Mr. Tech/a man.
Occasionally I attempt some humour.
It will likely go flat for a few days and even try a gap fill before reinvigorating for another leg up.
Doctors and nurses are still all the rage at the moment.
Re: RMD - Resmed
I'm hoping for a correction!
With ~+14% in two days, it has normalise. I'd like to add a healthcare stock. Seems I should have jumped last week.
I'm hoping for a correction!
With ~+14% in two days, it has normalise. I'd like to add a healthcare stock. Seems I should have jumped last week.
tech/a
No Ordinary Duck
- Joined
- 14 October 2004
- Posts
- 20,299
- Reactions
- 6,001
Re: RMD - Resmed
Ejeculation
You had me cacking myself
Until I realized you meant a climax
Personally I think your premature.
Now I can't get filling gaps
Up thrusts out of my mind!
Cracker
Ejeculation
You had me cacking myself
Until I realized you meant a climax
Personally I think your premature.
Now I can't get filling gaps
Up thrusts out of my mind!
Cracker
- Joined
- 27 December 2010
- Posts
- 1,729
- Reactions
- 48
Re: RMD - Resmed
Is Resmed the new Sirtex?
The current business is performing exceptionally well. It is certainly one of the top few, if not the best, continual growth stories that the ASX has ever seen.
Looks like the market however is starting to stretch the valuation a bit as Resmed is pushing further into increasing the perceived importance of sleep disordered breathing.
They are doing a good job here and positive results in their SERVE-HF trial next year could vastly increase their potential user-base.
I think that Resmed increasing awareness of SDB is a boon for the entire industry, of which they appear to remain at the forefront. It helps to have a growing pie so that existing pie eaters don't have to get overly worried about how much pie the others are eating.
Sourced a few days ago:
SAN DIEGO, March 12, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) today announced data from two studies about sleep-disordered breathing (SDB) in chronic heart failure will be presented at the 64th Annual Scientific Sessions of the American College of Cardiology, from March 14th through 16th.
"The data we are presenting are important because they point toward a connection between breathing disorders in sleep, like sleep apnea, and chronic heart failure," said ResMed Chief Medical Officer, Glenn Richards, M.D. "We look forward to learning the results of our landmark clinical study called SERVE-HF, that examines whether addressing sleep-disordered breathing in people with chronic heart failure improves survival."
Is Resmed the new Sirtex?
The current business is performing exceptionally well. It is certainly one of the top few, if not the best, continual growth stories that the ASX has ever seen.
Looks like the market however is starting to stretch the valuation a bit as Resmed is pushing further into increasing the perceived importance of sleep disordered breathing.
They are doing a good job here and positive results in their SERVE-HF trial next year could vastly increase their potential user-base.
I think that Resmed increasing awareness of SDB is a boon for the entire industry, of which they appear to remain at the forefront. It helps to have a growing pie so that existing pie eaters don't have to get overly worried about how much pie the others are eating.
Sourced a few days ago:
SAN DIEGO, March 12, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) today announced data from two studies about sleep-disordered breathing (SDB) in chronic heart failure will be presented at the 64th Annual Scientific Sessions of the American College of Cardiology, from March 14th through 16th.
"The data we are presenting are important because they point toward a connection between breathing disorders in sleep, like sleep apnea, and chronic heart failure," said ResMed Chief Medical Officer, Glenn Richards, M.D. "We look forward to learning the results of our landmark clinical study called SERVE-HF, that examines whether addressing sleep-disordered breathing in people with chronic heart failure improves survival."
- Joined
- 27 December 2010
- Posts
- 1,729
- Reactions
- 48
Re: RMD - Resmed
Have had to do a fair bit of reading to re-assure myself of the bolded quote. RMD is amongst my top holdings so I have to be careful of forming bias in my research and acting out of hope. My first reaction was similar to the above, then I thought about potential contagion affects, i.e. will this worry patients and will it potentially steer clinicians away from all RMD products? CPAP and AVS are distinctly different - but is there the potential for reputation damage?
I note that FPH also makes an ASV device, and comparatively they are not fairing as badly today.
Have had to do a fair bit of reading to re-assure myself of the bolded quote. RMD is amongst my top holdings so I have to be careful of forming bias in my research and acting out of hope. My first reaction was similar to the above, then I thought about potential contagion affects, i.e. will this worry patients and will it potentially steer clinicians away from all RMD products? CPAP and AVS are distinctly different - but is there the potential for reputation damage?
I note that FPH also makes an ASV device, and comparatively they are not fairing as badly today.
skc
Goldmember
- Joined
- 12 August 2008
- Posts
- 8,277
- Reactions
- 328
Re: RMD - Resmed
Are we sure? Below from Macquarie this morning.
Shades of ACR if you ask me.
It's not nearly as bad yet... but if some regulator got nervous and asks for further study to be done then if could potentially inflict a lot of damage.
Are we sure? Below from Macquarie this morning.
Shades of ACR if you ask me.
It's not nearly as bad yet... but if some regulator got nervous and asks for further study to be done then if could potentially inflict a lot of damage.
Wysiwyg
Everyone wants money
- Joined
- 8 August 2006
- Posts
- 8,424
- Reactions
- 274
Re: RMD - Resmed
Bought 2000 units at 8.33 on this recent pullback and am instantly at a loss so disappointed in this market reaction. I hope the October breakout isn't a support level.
Wysiwyg
Everyone wants money
- Joined
- 8 August 2006
- Posts
- 8,424
- Reactions
- 274
Re: RMD - Resmed
2 million share hand shake. Woot!
2 million share hand shake. Woot!
Wysiwyg
Everyone wants money
- Joined
- 8 August 2006
- Posts
- 8,424
- Reactions
- 274
Re: RMD - Resmed
Interesting how yesterdays bad news is followed today by upbeat news isn't it. Sold today for a loss of $2600. Tip for young players - if your subconscious/psyche has a loser glitch then you will find these events.
Interesting how yesterdays bad news is followed today by upbeat news isn't it. Sold today for a loss of $2600.
Tip for young players - if your subconscious/psyche has a loser glitch then you will find these events.
- Joined
- 1 October 2008
- Posts
- 3,733
- Reactions
- 388
Re: RMD - Resmed
Listen to you.
When I find myself making statements like that, it proves to be a good idea to take a position at a higher level cause something deep inside is really clear about it even if it's just half a position makes it more enjoyable watching it go back up when it inevitably does.
On a broader note, it is funny how these medical things have been smacked around simultaneously on news beyond generality of the sector.
PS Actually I don't think I make statements like that much any more. I just do something about it.
Listen to you.
When I find myself making statements like that, it proves to be a good idea to take a position at a higher level cause something deep inside is really clear about it even if it's just half a position makes it more enjoyable watching it go back up when it inevitably does.
On a broader note, it is funny how these medical things have been smacked around simultaneously on news beyond generality of the sector.
PS Actually I don't think I make statements like that much any more. I just do something about it.
greggles
I'll be back!
- Joined
- 28 July 2004
- Posts
- 4,207
- Reactions
- 3,828
ResMed pushing through $13 to all-time highs this morning after the release of its third quarter results. Revenue increased 15% to $591.6 million, a 15 percent increase compared to the same period of the prior year. Net income increased by 25%; non-GAAP net income up 32%. Operating cash flow of $149.1 million in the third quarter.
- Joined
- 24 December 2005
- Posts
- 2,601
- Reactions
- 2,062
ResMed buys US software company for $1bn
"Dual-listed sleep apnea device specialist ResMed is set to expand its software-as-a-service portfolio with the $US750 million ($A1.04bn) purchase of US healthcare software company, MatrixCare......"
http://www.thebull.com.au/articles/a/78162-resmed-buys-us-software-company-for-$1bn.html
It will be interesting to watch how the market reacts to this news.
"Dual-listed sleep apnea device specialist ResMed is set to expand its software-as-a-service portfolio with the $US750 million ($A1.04bn) purchase of US healthcare software company, MatrixCare......"
http://www.thebull.com.au/articles/a/78162-resmed-buys-us-software-company-for-$1bn.html
It will be interesting to watch how the market reacts to this news.
Similar threads
